07-Feb-2020 | Facts and Factors
Facts and Factors have authored “Femtech Market By Solution (Diagnostics, Therapeutics, and Digital Health), By Application (Reproductive Health, Pelvic and Uterine Care, Pregnancy and Nursing Care, and General Wellness) and By End-User (Individuals, Hospitals, Diagnostics Centers, and Others): Global Industry Perspective, Market Size, Statistical Research, Market Intelligence, Comprehensive Analysis, Historical Trends, and Forecasts, 2019–2026”. Based on our analysis, the global femtech market in 2019 is approximately USD 15,000 million and is anticipated to reach around USD 71,000 million by 2026. The anticipated CAGR for the femtech market is around 17% from 2020 to 2026.
The idea of digitally monitoring women's health is relatively new. Ida Tin, a Danish entrepreneur and founder of Clue, a period-and fertility-tracking device, coined the term femtech in 2016. As a business sector, femtech incorporates essentially every other digital or standard women's health tools, including mobile apps, internet-connected medical devices, wearables, hygiene products, and others.
Browse the full “Femtech Market By Solution (Diagnostics, Therapeutics, and Digital Health), By Application (Reproductive Health, Pelvic and Uterine Care, Pregnancy and Nursing Care, and General Wellness) and By End-User (Individuals, Hospitals, Diagnostics Centers, and Others): Global Industry Perspective, Market Size, Statistical Research, Market Intelligence, Comprehensive Analysis, Historical Trends, and Forecasts, 2019–2026” report at https://www.fnfresearch.com/femtech-market
In both developed and developing regions, the necessary transformation of the structure of healthcare and medicine does not catch up with the rapid progress of technology in the healthcare industry. Our society treats women's health issues as a prohibited topic, making it difficult for women to find medical care and healthcare advice. With accelerated technology adoption, females are primarily turning towards an accessible technological solution for their health-related issues. The solution includes diagnostics integrated with a smartphone, and wearables for a virtual meeting with doctors and experts. Although rising AI innovations and collaborations with public healthcare agencies are factors that can be asserted as significant industry propellers, demographics, urban-rural segregation, and fluctuating population socio-economic status can be regarded as strong market restraints. Furthermore, stigma related to women's health, particularly those related to sexual health, birth control, menstruation, and fertility can limit femtech market growth. Despite all the stigmas related to women's health issues, it is anticipated that increased funding in personalized wellness and consumer healthcare technology will create many opportunities for the global femtech market. Furthermore, continuous femtech innovations are likely to promote the global femtech market from experimental trials into the mainstream.
Solution-wise, the market is classified into diagnostics, therapeutics, and digital health. Digital health holds the leading share of the Femtech market, based on the solution sectors. This sector generated revenues attributable to USD 14,200 million in 2019 and is anticipated to reach USD 55,500 million by 2027. As per our team, this sector is anticipated to bolster at a CAGR of 17% from 2019 to 2026. Increasing physician adoption of digital healthcare technology for the prescription of chronic diseases such as Diabetes, Arthritis, Asthma, etc. accompanied by increasing government efforts to promote digital health, is expected to provide lucrative growth to this sector. Femtech's applications include pregnancy and nursing, pelvic & uterine health, reproductive health, and general health & wellness. Based on applications, the Pregnancy, and Nursing Care segment is projected to dominate the femtech industry. This segment generated revenues of USD 7,000 million in 2019 and is expected to reach USD 28,000 million by 2027. The government's favorable policies to enhance women's healthcare and raise awareness are likely to boost the growth of this segment. The industry is bifurcated into individuals, hospitals, fertility clinics, and surgical and diagnostic centers based on end-user. The segment for hospitals is expected to witness a CAGR of 17% during the forecast period. The growth of this segment is due to the accessibility of emergency facilities, well-established healthcare infrastructure, and the availability of skilled healthcare technicians.
In 2019 the region of North America retained the leading share of the global Femtech market. It accounted for 40% shares of the total market in 2019. The femtech industry in the Asia Pacific is expected to bolster at a CAGR of 18% for the forecast period. This is mainly due to the large number of patients that are vulnerable to numerous chronic and infectious diseases in countries such as India and China. Increased government support and general awareness of women's health care are expected to fuel the development of the regional industry in the years ahead. Additionally, the growing IT industry in APAC will further support the growth of the femtech industry.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 15,000 million |
Projected Market Size in 2026 |
USD 71,000 million |
CAGR Growth Rate |
17% CAGR |
Base Year |
2019 |
Forecast Years |
2019-2026 |
Key Market Players |
Aparito, LactApp, SteadySense GmbH Inc., Bonzun, Elvie, NaturalCycles Nordic AB, Grace.health, Hera Med Ltd., iBreve Ltd., Bloomlife, Niramai Health Analytix Pvt Ltd, Pregnolia AG, Ava Science Inc. |
Key Segment |
By Solution, By Application, By End-User, By Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Some of the essential players operating in the femtech market, but not restricted to include Aparito, LactApp, SteadySense GmbH Inc., Bonzun, Elvie, NaturalCycles Nordic AB, and Grace.health, Hera Med Ltd., iBreve Ltd., Bloomlife, Niramai Health Analytix Pvt Ltd, Pregnolia AG, Ava Science Inc.
This report segments the Femtech market as follows:
Global Femtech Market: By Solution Segmentation Analysis
- Diagnostics
- Therapeutics
- Digital health
Global Femtech Market: By Application Segmentation Analysis
- Reproductive health
- Pelvic and Uterine Care
- Pregnancy and Nursing Care
- General wellness
Global Femtech Market: By End-User Segmentation Analysis
- Individuals
- Hospitals
- Diagnostics Centers
- Others.
Global Femtech Market: Regional Segmentation Analysis
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-East Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- The Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle-East Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
